Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-29 @ 1:17 PM
Study NCT ID:
NCT06067568
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2023-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-28
First Submit QC Date:
None
Study First Post Date:
2023-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-12
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL